Retransplantation for recurrent hepatitis C: positive aspects.
1. The prevalence of retransplantation for hepatitis C (HCV) patients is stable (around 40%). 2. Survival models to predict outcome of retransplantation do not show that HCV is an independent variable with poor outcomes. 3. Using Model for End-Stage Liver Disease (MELD) scores from the United Network for Organ Sharing (UNOS) database from 1996-2002, retransplantation for HCV had similar outcomes to other causes of retransplantation. 4. Poorer outcomes were noted for retransplantation with MELD scores greater than 25. 5. Minimal survival thresholds need to be developed for retransplantation for all causes of retransplantation.
McCashland
Timothy M
TM
University of Nebraska Medical Center, Omaha 68198, USA. tmccash@surgery.unmc.edu
D006085:Graft Survival / Q000502:physiology; D006526:Hepatitis C / Q000401:mortality / Q000601:surgery*; D006801:Humans; D008103:Liver Cirrhosis / Q000601:surgery / Q000821:virology; D016031:Liver Transplantation / Q000401:mortality; D012008:Recurrence; D012086:Reoperation; D016019:Survival Analysis